MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on April 26, 2006; DOI: 10.1124/mol.106.022616


0026-895X/06/7001-194-205$20.00
Mol Pharmacol 70:194-205, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.106.022616v1
70/1/194    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mervine, S. M.
Right arrow Articles by Berlot, C. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mervine, S. M.
Right arrow Articles by Berlot, C. H.

Analysis of G Protein beta{gamma} Dimer Formation in Live Cells Using Multicolor Bimolecular Fluorescence Complementation Demonstrates Preferences of beta1 for Particular {gamma} Subunits

Stacy M. Mervine, Evan A. Yost, Jonathan L. Sabo, Thomas R. Hynes, and Catherine H. Berlot

Weis Center for Research, Geisinger Clinic, Danville, Pennsylvania

The specificity of G protein beta{gamma} signaling demonstrated by in vivo knockouts is greater than expected based on in vitro assays of beta{gamma} function. In this study, we investigated the basis for this discrepancy by comparing the abilities of seven beta1{gamma} complexes containing {gamma}1, {gamma}2, {gamma}5, {gamma}7, {gamma}10, {gamma}11, or {gamma}12 to interact with {alpha}s and of these {gamma} subunits to compete for interaction with beta1 in live human embryonic kidney (HEK) 293 cells. beta{gamma} complexes were imaged using bimolecular fluorescence complementation, in which fluorescence is produced by two nonfluorescent fragments (N and C) of cyan fluorescent protein (CFP) or yellow fluorescent protein (YFP) when brought together by proteins fused to each fragment. Plasma membrane targeting of {alpha}s-CFP varied inversely with its expression level, and the abilities of YFP-N-beta1YFP-C-{gamma} complexes to increase this targeting varied by 2-fold or less. However, there were larger differences in the abilities of the CFP-N-{gamma} subunits to compete for association with CFP-C-beta1. When the intensities of coexpressed CFP-C-beta1CFP-N-{gamma} (cyan) and CFP-C-beta1YFP-N-{gamma}2 (yellow) complexes were compared under conditions in which CFP-C-beta1 was limiting, the CFP-N-{gamma} subunits exhibited a 4.5-fold range in their abilities to compete with YFP-N-{gamma}2 for association with CFP-C-beta1. CFP-N-{gamma}12 and CFP-N-{gamma}1 were the strongest and weakest competitors, respectively. Taken together with previous demonstrations of a role for beta{gamma} in the specificity of receptor signaling, these results suggest that differences in the association preferences of coexpressed beta and {gamma} subunits for each other can determine which complexes predominate and participate in signaling pathways in intact cells.


Received January 18, 2006; accepted April 26, 2006

Address correspondence to: Catherine Berlot, Weis Center for Research, Geisinger Clinic, 100 North Academy Avenue, Danville, PA 17822-2623. E-mail: chberlot{at}geisinger.edu




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
P.-A. Vidi and V. J. Watts
Fluorescent and Bioluminescent Protein-Fragment Complementation Assays in the Study of G Protein-Coupled Receptor Oligomerization and Signaling
Mol. Pharmacol., April 1, 2009; 75(4): 733 - 739.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
E. A. Yost, S. M. Mervine, J. L. Sabo, T. R. Hynes, and C. H. Berlot
Live Cell Analysis of G Protein beta5 Complex Formation, Function, and Targeting
Mol. Pharmacol., October 1, 2007; 72(4): 812 - 825.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Hein, F. Rochais, C. Hoffmann, S. Dorsch, V. O. Nikolaev, S. Engelhardt, C. H. Berlot, M. J. Lohse, and M. Bunemann
GS Activation Is Time-limiting in Initiating Receptor-mediated Signaling
J. Biol. Chem., November 3, 2006; 281(44): 33345 - 33351.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics